• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[马约特岛麻风联合药物治疗的短期临床与组织学评估]

[Short-term clinical and histological evaluation of combination drug therapy of leprosy in Mayotte].

作者信息

Cnudde F, Julvez J, Rivière J P

出版信息

Acta Leprol. 1987 Apr-Jun;5(2):115-24.

PMID:3303804
Abstract

Leprosy in Mayotte affects 480 persons in a population of 80,000 inhabitants. 229 patients have been treated every day by association of Rifampicin, Clofazimine and Isoniazide. This study make a clinical, histological and bacteriological valuation after treatment, during a period of 3 years. With paucibacillary patients, whom received 1 year of mean treatment and after 2 years under observation, histology for short-dated can stay positive and active. With multibacillary patients, whom received 26 months of mean treatment and most of the time after 1 year under observation, the all of morphological index is negative, sometime bacteriology is positive, less often than histology. For middle- and long-dated, histology should allow a good valuation for disease evolution, specially for interpolar leprosy patients.

摘要

马约特岛的麻风病在8万居民中有480人患病。每天有229名患者接受利福平、氯法齐明和异烟肼联合治疗。本研究在3年期间对治疗后的患者进行了临床、组织学和细菌学评估。对于少菌型患者,平均接受1年治疗,观察2年后,短期组织学检查可能仍呈阳性且活跃。对于多菌型患者,平均接受26个月治疗,大多数情况下观察1年后,所有形态学指标均为阴性,有时细菌学检查呈阳性,比组织学检查阳性的情况少见。对于中长期患者,组织学检查有助于很好地评估疾病进展,特别是对于中间型麻风患者。

相似文献

1
[Short-term clinical and histological evaluation of combination drug therapy of leprosy in Mayotte].[马约特岛麻风联合药物治疗的短期临床与组织学评估]
Acta Leprol. 1987 Apr-Jun;5(2):115-24.
2
[Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].[基于利福平与氯法齐明使用的马约特岛麻风病防治项目]
Acta Leprol. 1982 Jul-Sep(88):19-22.
3
Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Indian J Lepr. 1987 Jan-Mar;59(1):54-62.
4
Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.利福平、氯法齐明和氨苯砜联合多药疗法治疗多菌型麻风病例的评估。
Indian J Lepr. 1984 Jan-Mar;56(1):78-85.
5
Short term chemotherapy of paucibacillary leprosy.
Indian J Lepr. 1986 Oct-Dec;58(4):549-54.
6
Daily multidrug therapy for leprosy; results of a fourteen-year experience.麻风病的每日多药疗法;十四年经验结果
Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44.
7
Evaluation of two multidrug regimen in hospitalised multibacillary cases.
Indian J Lepr. 1989 Apr;61(2):196-205.
8
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.多药联合疗法治疗多菌型麻风的疗效:对34例接受多药联合方案治疗直至皮肤涂片转阴的多菌型麻风患者的长期随访
Lepr Rev. 2003 Jun;74(2):141-7.
9
Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.在瘤型麻风的初始治疗中,每月一次服用利福平(1200毫克),同时每日服用氨苯砜(100毫克)和氯法齐明(100毫克)。
Indian J Lepr. 1984 Jan-Mar;56(1):63-70.
10
Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
Lepr India. 1981 Apr;53(2):248-58.